This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Mon May 20, 2013 12:43 pm

View unanswered posts | View active topics


Board index » Multiple Sclerosis » General Discussion

All times are UTC - 8 hours [ DST ]



Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 
  Print view Previous topic | Next topic 
Author Message
squiffy2
PostPosted: Fri Jan 21, 2011 5:27 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1684
Image


European regulators recommended approval of Novartis's multiple sclerosis pill Gilenya on Friday, consolidating its lead as the first pill to treat the disease.

The green light from the European Medicines Agency in London follows approval in the United States last month, where it has gone on sale at an average cost of $48,000 per patient a year.

Recommendations for marketing approval by the agency's Committee for Medicinal Products for Human Use (CHMP) are normally endorsed by the European Commission within a couple of months.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis
Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  Page 1 of 1
  [ 1 post ] 

Board index » Multiple Sclerosis » General Discussion

All times are UTC - 8 hours [ DST ]

Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Merck KGaA to ask EU agency to reconsider MS oral drug

squiffy2

0

598

Mon Oct 11, 2010 2:44 am

squiffy2 View the latest post

There are no new unread posts for this topic. Oral MS drug Gilenya® approved in Australia and Switzerland

squiffy2

0

742

Mon Jan 31, 2011 7:15 am

squiffy2 View the latest post

There are no new unread posts for this topic. Oral MS drug Cladribine rejected by European drug agency

squiffy2

1

851

Fri Sep 24, 2010 3:27 am

LR1234 View the latest post

There are no new unread posts for this topic. If Gilenya’s ingredient (fingolimod) costs only $14 a month

marcinl0

2

1165

Mon Oct 25, 2010 6:44 am

HarryZ View the latest post

There are no new unread posts for this topic. Messing with my medication

MrsGeorge

3

1188

Wed Jun 11, 2008 8:12 pm

Artifishual View the latest post

 


Who is online

Users browsing this forum: No registered users

You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to: